Observational Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Aug 14, 2019; 25(30): 4246-4260
Published online Aug 14, 2019. doi: 10.3748/wjg.v25.i30.4246
Table 4 Number of responders matching each predetermined patient profile
Profilesn
Compound
1Patients with active disease (MIBDI A/B/C) and a history of hospitalization during the preceding 12 mo94
2Patients with significantly active disease (MIBDI A/B/C) treated with immunomodulators and biologic agents52
3Patients in remission while treated with immunomodulators and/or biologic agents26
4Patients in remission treated only with mesalamine or receiving no treatment90
5Patients aged 21-65 yr with any active disease (MIBDI A/B/C/D)341
6Patients with any active disease (MIBDI A/B/C/D) and a previous surgery for IBD92
7Patients older than age 50 yr, diagnosed during the preceding 12 mo8
8Patient younger than age 21 yr, diagnosed during the preceding 12 mo21
Simple
9Patients diagnosed during the preceding 12 mo92
10Patients hospitalized during the preceding 12 mo163
11Patients diagnosed more than 10 yr ago212
12Patients who had surgery during the preceding 12 mo39
13Patients with highly disease activity (MIBDI A/B)246
14Patients diagnosed at age > 50 yr72
15Patients who were unemployed or received disability pension during the preceding 12 mo45